Corporate Governance

The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on

The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on

CSRC prevents backdoor listing from circumventing regulation.

The new Foreign Investment Industrial Guidance Catalogue has opened up and closed off a number of key industries accessible to overseas investors. It may be the last version as China moves to further reform the FDI framework

The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline

The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline

Foreign investment catalogue revised to allow more foreign shareholding.

The millions in fines imposed on polluters and arrests of executives indicate the seriousness of China's efforts to enforce the year-old revised Environmental Protection Law. This feature lists some of the things multinationals can do to stay out of trouble

The millions in fines imposed on polluters and arrests of executives indicate the seriousness of China's efforts to enforce the year-old revised Environmental Protection Law. This feature lists some of the things multinationals can do to stay out of trouble